The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts on May 22 to discuss COVID-19 ...

The Trump administration's effort to impose new requirements on Novavax's COVID-19 vaccine is sowing uncertainty about other ...

Yes, according to leading vaccine physician Paul Offit, who denounced the new placebo-controlled trial requirements for ...

A blanket requirement for placebo-controlled trials threatens research ethics and vaccine access, it’s being argued.

Senior leaders at the US Food and Drug Administration began pushing Moderna Inc. and Pfizer Inc. to file for full, formal ...

The FDA is expected to unpause the only protein-based COVID-19 vaccine's transition from emergency approval to full approval.

According to the WSJ, the universal vaccine project is being pioneered by two recently appointed senior scientists in the NIH ...

The FDA has already delayed the approval of Novavax’s updated Covid vaccine, requiring the company to carry out a new ...

The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat ...

Novavax is recognized for its expertise in vaccine science, focusing on protein-based nanoparticles and adjuvants. The company’s growth strategy revolves around diversifying partnerships by out ...

Back in November 2023, pharmaphorum travelled to Uppsala, Sweden, for a Novavax press conference, the company celebrating a decade of doing what it does best: vaccines. From COVID-19 to malaria ...